Dopamine Agonists: all 968 studies that test it
Page 5 of 10. Open to participants first (53), then studies with results posted, then the rest; newest registration first within each.
- Long-term Study Of Ropinirole In Restless Legs SyndromeCompletedNCT00329602Phase 4Results posted
- Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)CompletedNCT00321854Phase 4Results posted
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode PsychosisCompletedNCT00320671Phase 4Results posted
- An Open-Label Trial of Aripiprazole in Autism Spectrum DisordersCompletedNCT00308074Phase 2Results posted
- Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive SymptomsCompletedNCT00297778Phase 4Results posted
- Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of Parkinson SymptomsCompletedNCT00296192Phase 2Results posted
- Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's DiseaseCompletedNCT00292227Phase 1Results posted
- Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic ChangesTerminatedNCT00288353Phase 3Results posted
- Treatment of Children With ADHD Who do Not Fully Respond to StimulantsTerminatedNCT00279409Phase 2Results posted
- A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed EpisodeCompletedNCT00277212Phase 4Results posted
- Pramipexole Conversion to Ropinirole Controlled Release (CR)CompletedNCT00275275Phase 3Results posted
- A Study of Aripiprazole (Abilify) in Patients With Bipolar ManiaCompletedNCT00261443Phase 4Results posted
- Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)CompletedNCT00256854Phase 3Results posted
- Trial of Aripiprazole in the Treatment of CD in AdolescentsCompletedNCT00250705Phase 4Results posted
- Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT00241176Phase 4Results posted
- Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical TrialsCompletedNCT00239356Phase 3Results posted
- 12- Week Open Label Treatment of Refractory Bipolar DepressionCompletedNCT00223496Phase 4Results posted
- Abilify as an Adjunctive Treatment for Refractory DepressionCompletedNCT00220636Phase 4Results posted
- Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's DiseaseCompletedNCT00219284Phase 4Results posted
- Medications for Stopping Cocaine Dependence and Preventing RelapseCompletedNCT00218023Phase 2Results posted
- The Effects of Aripiprazole on the Processing of Rewards in SchizophreniaTerminatedNCT00209027Not applicableResults posted
- Metabolic Effects of Antipsychotics in ChildrenCompletedNCT00205699Phase 4Results posted
- A Study Examining the Use of a Migraine Medicine in the Treatment of Two Migraine Attacks in Patients Who Have Increased Skin SensitivityCompletedNCT00203268Not applicableResults posted
- Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With AutismCompletedNCT00198107Phase 3Results posted
- Study of Aripiprazole (Abilify) in Children With Symptoms of ManiaCompletedNCT00194077Phase 3Results posted
- Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar DisorderCompletedNCT00194012Phase 3Results posted
- Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) PatientsCompletedNCT00144300Phase 4Results posted
- Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic ImpactCompletedNCT00141518Phase 4Results posted
- Aripiprazole in Children and Adolescents With Bipolar I DisorderCompletedNCT00110461Phase 3Results posted
- A Study of Aripiprazole in Patients With Major Depressive DisorderCompletedNCT00105196Phase 3Results posted
- Aripiprazole Open-Label, Safety and Tolerability StudyCompletedNCT00102518Phase 3Results posted
- Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and AdolescentsCompletedNCT00102479Phase 1Results posted
- Aripiprazole in Adolescents With SchizophreniaCompletedNCT00102063Phase 3Results posted
- Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa TherapyCompletedNCT00099268Phase 3Results posted
- Lexapro and Pramipexole and to Treat Major DepressionCompletedNCT00086307Phase 2Results posted
- Switching Medication to Treat SchizophreniaCompletedNCT00044655Phase 4Results posted
- A Study in Healthy People to Compare Two Tablet Formulations of PramipexoleCompletedNCT07727785Phase 1
- Levodopa for Diabetic RetinopathyCompletedNCT07444892Phase 2
- Bioequivalence Study to Compare Brexpiprazole 4 mg Film Coated Tablets Versus RXULTI 4 mg Film Coated Tablet (Brexpiprazole)CompletedNCT07266792Phase 1
- Neurobiological Mechanisms of Pathological Rumination and Effects of AripiprazoleActive, not recruitingNCT06937476Not applicable
- A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult SubjectsCompletedNCT06921590Phase 1
- A Reduced Dose of Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Pregnancy LossWithdrawnNCT06909123Phase 2
- A Study to Assess the Relative Bioavailability of Oral Tavapadon in Healthy Adult ParticipantsCompletedNCT06895356Phase 1
- Dopamine and Brain Computer InterfaceCompletedNCT06729658Early Phase 1
- Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMDActive, not recruitingNCT06707753Phase 1/2
- Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIVSuspendedNCT06705478Phase 2
- A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPDActive, not recruitingNCT06533553Phase 2
- Phase III Long-Term Extension Study With DexpramipexoleTerminatedNCT06388889Phase 3
- Behavioural Profiling of Disease-related Cognitive and Motor Impairment in PDCompletedNCT06275633Not applicable
- Pramipexole to Enhance Social ConnectionsActive, not recruitingNCT06269146Phase 2
- Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's DiseaseCompletedNCT06247410Phase 2
- Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With SchizophreniaCompletedNCT06236451Phase 4
- A TQT Study to Evaluate the Electrocardiographic Effects of Carbidopa in Healthy SubjectsCompletedNCT06161220Phase 1
- Continuation Study for LatozinemabTerminatedNCT06111014Phase 3
- Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOSCompletedNCT05981742Phase 2
- The Correlation of Reduction of Levodopa and Non-motor Symptoms of Parkinson's Disease After Deep Brain StimulationCompletedNCT05901350Not applicable
- Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use DisorderCompletedNCT05886582Phase 2
- Long-term Efficacy of Pramipexole in Anhedonic DepressionCompletedNCT05825235Phase 3
- A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)TerminatedNCT05813288Phase 3
- Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P&C Labs (Pellets & CR Products), Egypt) Versus Abilify 10 mg Orodispersible Tablets (Otsuka Pharmaceutical Netherlands B.V., Netherlands)CompletedNCT05804721Phase 1
- A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.TerminatedNCT05763121Phase 3
- A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic AsthmaActive, not recruitingNCT05748600Phase 3
- Multiple-dose Trial to Determine the Clinical Bioequivalence Between Tavapadon Tablets in Participants With Parkinson's DiseaseCompletedNCT05610189Phase 1
- Study to Evaluate the Effects of Cytochrome P450 (CYP) 3A4 Inducer Carbamazepine on Tavapadon Pharmacokinetics in Healthy Adult ParticipantsCompletedNCT05581823Phase 1
- Bioequivalence Study of Aripiprazole in Healthy Adult Subjects Under Fasting ConditionCompletedNCT05532254Phase 1
- RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)CompletedNCT05531591Phase 4
- Cabergoline as a Preventive Treatment for Chronic MigraineCompletedNCT05525611Not applicable
- Open-label Brexpiprazole fMRI Trial in Adults With Major Depressive Disorder and AnxietyWithdrawnNCT05504486Phase 4
- Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid ExposureActive, not recruitingNCT05463367Phase 2
- To Evaluate Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Severe Renal Impairment Compared to Participants With Normal Renal FunctionCompletedNCT05404542Phase 1
- To Evaluate the Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Mild and Moderate Hepatic Impairment Compared to Participants With Normal Hepatic FunctionCompletedNCT05404529Phase 1
- Efficacy of Treatment With Pramipexole or Risperidone in Patients With Refractory Obsessive-compulsive Disorder (OCD)WithdrawnNCT05401019Phase 2
- Pramipexole for Anhedonic DepressionCompletedNCT05355337Phase 3
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of PUR3100 in Health AdultsCompletedNCT05351086Phase 1
- A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy SubjectsCompletedNCT05337254Phase 1
- The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of SchizophreniaCompletedNCT05322031Phase 4
- Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference ProductCompletedNCT05250141Phase 1
- Impact of Aripiprazole on Postoperative Analgesia in Laparoscopic HysterectomyCompletedNCT05103410Phase 4
- Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participants With Parkinson's DiseaseCompletedNCT05094050Phase 1
- Novel Non-opioid Post-surgical Pain Treatment in FemalesWithdrawnNCT05087914Phase 2
- Lactation Inhibition, the Efficiency of Vitamin B6 Versus CabergolineCompletedNCT05024422Not applicable
- Treating Leg Symptoms in Women With X-linked AdrenoleukodystrophyActive, not recruitingNCT05003648Phase 4
- eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.CompletedNCT04990284Phase 4
- Dopaminergic Therapy for Frontotemporal Dementia PatientsCompletedNCT04937452Phase 2
- Monocentric, Prospective Study to Assess the Pharmacokinetic Profile of Continuous and Diurnal Subcutaneous Apomorphine Infusion in Patients With Parkinson's DiseaseCompletedNCT04887467Phase 4
- Apomorphine Effects on Pain in Parkinson's DiseaseStatus unknownNCT04879134Phase 2/3
- Management of Hypertension in the Early Postpartum: a Randomized Controlled TrialCompletedNCT04835233Phase 4
- Clinical Efficacy and Change of Life Quality Through Using the Comprehensive Behavioral Intervention Treatment for TicsWithdrawnNCT04765085Not applicable
- Histaminergic Basis of Fatigue in Multiple SclerosisWithdrawnNCT04764383Phase 2
- Open-label Trial in Parkinson's Disease (PD)CompletedNCT04760769Phase 3
- Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's DiseaseCompletedNCT04750226Phase 3
- Research on Translational Outcomes of Alcohol (Project RETRO)WithdrawnNCT04742348Phase 4
- Dopaminergic Dysfunction in Late-Life DepressionCompletedNCT04469959Phase 2
- Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model BuildingStatus unknownNCT04446234Phase 4
- Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's DiseaseCompletedNCT04413344Phase 1/2
- Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's DiseaseCompletedNCT04379050Phase 3
- Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid ResponseCompletedNCT04351126Phase 2
- Carbetocin Versus Ergometrin in the Prevention of Postpartum HemorrhageStatus unknownNCT04300452Phase 4
- A Study to Investigate the Effect of MCE on Glucose and Insulin Responses in Healthy MalesCompletedNCT04296045Not applicable
- A 2-Part Trial of CVL-751 in Subjects With Parkinson's DiseaseCompletedNCT04295642Phase 1